The Latest Breaking News on Pharma

Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million fund.

Only 10% of Chicagoans have gotten their updated COVID-19 booster. Perhaps we need a jolt of that urgency and desperation we once felt to protect ourselves from coronavirus at the height of the pandemic.

In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ: MRNA) was discussed frequently on Benzinga's PreMarket Prep show. 

The Ministry of Public Health kicked off the first round of Covid-19 vaccinations for the youngest demographic in the country on Wednesday.

In tonight's edition: The deaths of dozens of children in Gambia from suspected contaminated medicinal syrups sees Indian authorities shut down production at a pharmaceuticals company in Delhi. And the WHO hopes to start clinical trials for the strain of Ebola behind a deadly outbreak in Uganda. Finally, violent child…

Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) announced it will conduct two separate Phase 3 clinical trials to study psilocybin-assisted therapy on Treatment-Resistant Depression (TRD), 

Moderna vaccine has been approved for children six years and older, while children as young as five can get Pfizer

Many pharmacies in Finland have run out of iodine tablets a day after the Nordic country’s health ministry recommended that households purchase a single dose in a case of radiation hazard emergency amid increasing fears of a nuclear incident due to Russia’s war in Ukraine

COVID-19 vaccine makers Pfizer Inc. and Moderna Inc. received U.S. regulatory clearances for their omicron-targeted boosters for children as young as 5.

Bivalent booster is to increase protection for children as US restrictions ease, schools resume in-person learning.

The booster shots are now authorized for children as young as 5 years old.